SA’s HIV response, long praised globally, faces a serious setback as Deputy President Paul Mashatile warns that 1.1m people have been lost to follow-up, undermining progress in treatment outcomes.
SA’s National Essential Medicines List Committee (NEMLC) has prioritised a review of glucagon-like peptide-1 (GLP-1) medicines, signalling a potential shift in national strategies for managing type 2 diabetes and obesity. – Business Day (1 Dec 2025)
SA is battling a fast-growing black market for GLP-1 agonists, driven by soaring demand for weight-loss injections and the unaffordability of legitimate products like Ozempic, Wegovy and Mounjaro.
The University of Cape Town has launched the African Genomics Short Course (AGSC), a 10-day training programme aimed at strengthening African leadership in global genetic research and addressing the continent’s severe underrepresentation in genomic data. – TimesLive (1 Dec 2025)